🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Martin Offringa

Hospital for Sick Children

ORCID: 0000-0002-4402-5299

Also affiliated with SickKids Foundation, Institute for Clinical Evaluative Sciences

Decision SciencesSocial SciencesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.417Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation

Ewha Medical Journal(2025)10.12771/emj.2025.00409
Top 44%
0.417DataRank
Top 44%7 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

Papers

Driven by 14 papers — median percentile 56. Top paper: “CONSORT 2025 Statement”.

CONSORT 2025 Statement

JAMA(2025)10.1001/jama.2025.4347
N/A
3.8DataRank · unranked
230 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +35 more

CONSORT 2025 statement: updated guideline for reporting randomised trials

The Lancet(2025)10.1016/s0140-6736(25)00672-5
N/A
3.6DataRank · unranked
337 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +35 more

CONSORT 2025 statement: updated guideline for reporting randomized trials

Nature Medicine(2025)10.1038/s41591-025-03635-5
N/A
3.3DataRank · unranked
215 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +35 more

SPIRIT 2025 statement: updated guideline for protocols of randomised trials

BMJ(2025)10.1136/bmj-2024-081477
N/A
2.4DataRank · unranked
292 citations

Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins +34 more

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials

BMJ(2025)10.1136/bmj-2024-081124
N/A
1.5DataRank · unranked
126 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

CONSORT 2025 statement: updated guideline for reporting randomised trials

BMJ(2025)10.1136/bmj-2024-081123
N/A
0.955DataRank · unranked
580 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

SPIRIT 2025 statement: updated guideline for protocols of randomized trials

Nature Medicine(2025)10.1038/s41591-025-03668-w
N/A
0.680DataRank · unranked
92 citations

Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins +35 more

CONSORT 2025 statement: Updated guideline for reporting randomised trials

PLOS Medicine(2025)10.1371/journal.pmed.1004587
N/A
0.546DataRank · unranked
37 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials

PLOS Medicine(2025)10.1371/journal.pmed.1004589
N/A
0.457DataRank · unranked
20 citations

Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins +34 more

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation

Ewha Medical Journal(2025)10.12771/emj.2025.00409
Top 44%
0.417DataRank
Top 44%7 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited

Journal of Clinical Epidemiology(2018)10.1016/j.jclinepi.2017.11.016
N/A
0.208DataRank · unranked
3 citations

Mufiza Farid-Kapadia, Martin Offringa, Zulfiqar A. Bhutta, Yvonne Maldonado, Mufiza Farid‐Kapadia +3 more

Co-developing The Canadian MPS Registry: A longitudinal rare disease patient registry

Molecular Genetics and Metabolism(2024)10.1016/j.ymgme.2023.107964
N/A
0DataRank · unranked
0 citations

Michal Inbar-Feigenberg, Kim Angel, Pranesh Chakraborty, Monica Lamoureux, John Adams +19 more

Study Preregistration: Measuring What Matters: Development and Dissemination of a Core Outcome Set for Pediatric Anxiety Disorders Clinical Trials

Journal of the American Academy of Child & Adolescent Psychiatry(2023)10.1016/j.jaac.2023.01.016
N/A
0DataRank · unranked
3 citations

Riddhi Desai, Samantha J. Anthony, Paul Arnold, Alexa Bagnell, BORIS BIRMAHER +25 more

Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration

BMJ(2024)10.1136/bmj-2023-078525
N/A
0DataRank · unranked
28 citations

Philippa Davies, Derek Stewart, Christopher J. Weir, Amber Young, Jane Blazeby +31 more